Next Article in Journal
Is There Any Benefit to the Use of Antibiotics with Indwelling Catheters after Urologic Surgery in Adults
Next Article in Special Issue
Seminal Bacterioflora of Two Rooster Lines: Characterization, Antibiotic Resistance Patterns and Possible Impact on Semen Quality
Previous Article in Journal
Differentiation of Escherichia fergusonii and Escherichia coli Isolated from Patients with Inflammatory Bowel Disease/Ischemic Colitis and Their Antimicrobial Susceptibility Patterns
Previous Article in Special Issue
Prevalence and Phenotypic Antimicrobial Resistance among ESKAPE Bacteria and Enterobacterales Strains in Wild Birds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 12
Issue 1
10.3390/antibiotics12010155
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid

by
Andrea Laconi
1,
Roberta Tolosi
1,
Ilias Apostolakos
2 and
Alessandra Piccirillo
1,*
1
Department of Comparative Biomedicine and Food Science, University of Padua, 35020 Legnaro, PD, Italy
2
Dairy Research Institute, Hellenic Agricultural Organization “DIMITRA”, 45221 Ioannina, Greece
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(1), 155; https://doi.org/10.3390/antibiotics12010155
Submission received: 20 December 2022 / Revised: 9 January 2023 / Accepted: 10 January 2023 / Published: 11 January 2023
(This article belongs to the Special Issue Antimicrobial and Antifungal Resistance in Domestic Animals, Synanthropic Species and Wildlife)
Browse Figures
Versions Notes

Abstract

:
Escherichia coli able to produce extended spectrum β-lactamases (ESBLs) and plasmid-mediated AmpC β-lactamases (pAmpCs) represents a serious threat to public health, since these genes confer resistance to critically important antimicrobials (i.e., third generation cephalosporins) and can be transferred to non-resistant bacteria via plasmids. E. coli are known to be able to form a biofilm, which represents a favorable environment for the exchange of resistance determinants. Here, we assessed the ability of 102 ESBL/pAmpC-producing E. coli isolated from the broiler production pyramid to form a biofilm and to identify genetic factors involved in biofilm formation. All but one of the ESBL/pAmpC-producing E. coli were able to form a biofilm, and this represents a great concern to public health. E. coli belonging to phylogroups D, E, and F, as well as strains harboring the blaCTX-M-type gene, seem to be associated with an increased biofilm capability (p < 0.05). Furthermore, virulence genes involved in adherence and invasion (i.e., csgBAC, csgDEFG, matABCDEF, and sfaX) seem to enhance biofilm formation in E. coli. Efforts should be made to reduce the presence of ESBL/pAmpC- and biofilm-producing E. coli in the broiler production pyramid and, therefore, the risk of dissemination of resistant bacteria and genes.

1. Introduction

In recent years, Escherichia coli antibiotic resistance has increased significantly, posing a threat to animal and human health [1]. Among the resistance mechanisms emerging in this species, extended spectrum β-lactamases (ESBLs) and plasmid-mediated AmpC β-lactamases (pAmpCs) represent a great concern for public health. Indeed, they hinder resistance to third generation cephalosporins, which are considered by the World Health Organization (WHO) as Highest Priority Critically Important Antimicrobials (HPCIA), essential for the treatment of serious bacterial infections and one of the few alternatives to the treatment of sepsis and respiratory tract infections in various animal species, including humans. Furthermore, ESBL/pAmpC genes are located on mobile genetic elements (MGEs), allowing their exchange between bacteria [2].
E. coli persisting in the environment and especially those residing within biofilms can also contribute to the spread of antimicrobial resistance. Indeed, biofilm is known to be a hot spot for horizontal gene transfer (HGT) within and between bacterial species [3,4]. Biofilms are heterogeneous structures formed by bacterial populations enclosed in an extracellular matrix and able to colonize abiotic and biotic surfaces [5]. Bacteria living within biofilms show several advantages compared to those in planktonic form, such as greater protection against chemical, biological, and mechanical agents, thus surviving common disinfection and cleaning treatments [6].
The presence of ESBL/pAmpC-producing E. coli (ESBL/pAmpC-EC) has been detected at different levels of the poultry production chain, and the consumption of contaminated chicken meat has been suggested as one of the main sources of human infection caused by resistant E. coli [7]. Similarly, biofilm-producing E. coli have been identified on the surface of poultry farms, poultry meat processing facilities, and poultry meat packaging, showing themselves to be highly resistant to disinfection and sanitation procedures, and, therefore, representing a threat to consumers’ health [8].
In the present study, the biofilm formation ability of 102 ESBL/pAmpC-producing E. coli strains isolated from different stages of the broiler production pyramid was evaluated in vitro by using a microtiter assay and correlated with environmental and genetic factors that could be involved in biofilm formation.

2. Results

2.1. Biofilm Production Assay

All but one of the ESBL/pAmpC-EC investigated was able to form biofilm. Based on the results of the mean optical densities (O.D.), strains were classified as strong (n = 7, 6.86%, 95% confidence of interval (CI) 1.87–11.85%), moderate (n = 31, 30.39%, 95% CI 21.31–39.47%), weak (n = 63, 61.76%, 95% CI 52.17–71.36%), and non-biofilm producers (n = 1, 0.98%, 95% CI 0.00–2.92%). The mean O.D. values for each group are depicted in Figure 1, and statistically significant differences in O.D. between groups were observed (p < 0.05).

2.2. Distribution of Biofilm-Producing ESBL/pAmpC E. coli along the Poultry Production Pyramid

The frequency of biofilm classes among sampling sites (i.e., production chains and stages of the production pyramid) is listed in Table 1.
Biofilm-producing ESBL/pAmpC-EC were identified in all production chains, and even though they were not statistically significant, some differences in the distribution of the biofilm classes between chains was observed (Figure 2a). Indeed, chain C showed the highest prevalence of weak producers (75% vs. 54.05% and 57.58% of chains A and B, respectively), chain A of moderate producers (40.54% vs. 30.30% and 18.75% of chains B and C, respectively), and chain B of strong producers (9.09% vs. 5.41% and 6.25% of chains A and C, respectively). Multiple comparisons between the corrected mean O.D. revealed a significant difference (p = 0.0085) between chain A and chain C (Figure 2b), confirming the association of the latter with weak biofilm-producing strains.
No strong producers were identified in breeder chicks, and the prevalence of moderate and strong biofilm producers seemed to increase in adult birds (Figure 2c); however, no significant differences between production stages were identified. Similarly, no significant differences in corrected mean O.D. were detected between production stages (Figure 2d).

2.3. Genetic Characteristic of Biofilm-Producing ESBL/pAmpC E. coli

The ability to produce the biofilm of the investigated ESBL/pAmpC-EC seems to be associated with the genotype. In detail, weak biofilm production was observed more frequently in phylogroup A compared to phylogroup B1 (p = 0.023) and in phylogroup B2 than in phylogroups B1 (p = 0.0068), E (p = 0.0464), and F (p = 0.0361). On the other hand, moderate biofilm-producing strains were more frequent in phylogroup B1 than in phylogroups A and B2 (p = 0.0458 and p = 0.0235, respectively). Notably, no strong biofilm producers were detected in phylogroups A, B2, and C, and no associations were identified between phylogroups and strong biofilm-producing strains. The frequency of biofilm classes among phylogroups is reported in Table 2.
The statistical analysis of the corrected mean O.D. seems to confirm the association between strains belonging to phylogroup A and the limited ability to form biofilms, since differences were observed between this phylogroup and phylogroups D, E, and F (p = 0.0104, p = 0.0001, and p < 0.0001, respectively) (Figure 3a).
Interestingly, correlations were identified between biofilm producing classes and the frequency of ESBL/pAmpC-encoding genes. Indeed, strains harboring blaCMY-2 were associated with weak biofilm production (p = 0.0326), while blaCTX-M-type gene was associated with moderate biofilm production ability (p = 0.0436). The distribution of biofilm classes among strains harboring different ESBL/pAmpC genes is reported in Table 2. According to the association between ESBL/pAmpC genes and biofilm classes, the corrected mean O.D. was significantly higher in strains carrying the blaCTX-M-type gene than those harboring blaCMY-2 and blaSHV genes (p = 0.0253 and p = 0.0144, respectively) (Figure 3b).

2.4. Analysis of Virulence Genes Associated with Biofilm Formation

Out of 70 virulence genes associated with biofilm formation, adherence, and cell invasion (Table S1), 29 were detected among the 102 strains included in this study. Nine genes (i.e., csgB, csgC, csgD, csgE, csgF, fimF, fimG, hha, and papC) were identified in all strains, while the remaining genes were detected only in some strains (min = 1 and max = 100). No associations were identified between the number of genes and the ability to form biofilm, and strains belonging to different biofilm classes harbored a similar number of virulence genes (mean = 20.63 and 95% CI 19.84–21.43, mean = 20.52 and 95% CI 19.31–21.72, and mean = 20.86 and 95% CI 18.56–23.15, for weak, moderate, and strong producers, respectively). Hierarchical clustering analyses based on the frequency of 21 variable virulence genes did not show any clear cluster of strains according to the explanatory variables (i.e., stage, chain, phylogroup, ESBL/pAmpC gene, and biofilm class) (Figure 4).
Statistical analysis showed a significant reduction in corrected mean O.D. in strains harboring tsh gene (p = 0.015), while the presence of operons csgBAC (p < 0.0001), csgDEFG (p = 0.0082), matABCDEF (p = 0.0082), and gene sfaX (p = 0.0127) was associated with increased corrected mean O.D. (Figure 5). No other statistically significant differences were identified between the frequency of virulence genes and the corrected mean O.D. Any multivariable analysis was precluded by the high collinearity between the investigated genetic components.

3. Discussion

Biofilm production provides bacteria with remarkable survival advantages, allowing protection against mechanical, chemical, and biological agents, and it encourages the transfer of antimicrobial resistance genes between bacteria. Indeed, bacteria that reside in a biofilm within the water pipeline or on the surfaces of livestock productions are less susceptible to detergent and antimicrobial treatments.
The vast majority (98.03%) of ESBL/pAmpC-EC strains isolated from the three different chains of an integrated Italian poultry company were able to produce biofilm, confirming the extent of this issue in E. coli carrying ESBL/pAmpC genes [9,10].
Of concern, biofilm-producing ESBL/pAmpC-EC seem to be disseminated throughout the broiler production pyramid; although a higher prevalence of moderate and strong producing strains was observed in adult birds compared to chicks. These findings, together with differences in the ability to form the biofilms of strains isolated from different production chains, seem to suggest that biofilm-producing ESBL/pAmpC-EC emerged in the poultry pyramid as result of the combinatory effect of vertical transmission (i.e., from generation to generation), environmental contamination, within and between farms transmission, and resistant bacteria proliferation, as previously hypothesized [11]. Furthermore, all ESBL/pAmpC-EC isolated from carcasses were able to form biofilms; considering the direct link between meat contaminated with ESBL/pAmpC-EC and human exposure; this represents a concern for human health [7,12]. Indeed, surface contamination with biofilm-producing ESBL/pAmpC-EC during the manipulation of the carcasses might promote the establishment of persistent biofilms in slaughterhouses, contributing to the dissemination of bacteria resistant to third generation cephalosporins through the food chain, as well as to operators.
Relations between biofilm classes and genetic factors were also identified. Indeed, strains belonging to phylogroups A and B2 seemed to have lower ability to form biofilms compared to other phylogroups (B1, D, E, and F). High biofilm production was detected for strains belonging to phylogroups associated with extra-intestinal pathogenicity (D, E, and F), while commensal phylogroup A showed the lowest correct mean O.D.; however, this pattern was not observed for phylogroups B2 (associated with weak producers) and B1 (associated with moderate producers), considered pathogenic and commensal, respectively. Although an association between phylogroups and biofilm formation ability might be plausible, no direct links between biofilm production and extra intestinal pathogenicity can be established. Strains harboring blaCTX-M-type gene seem to be associated with higher biofilm production in comparison to those carrying blaCMY-2 and blaSHV genes. This finding seems to agree with previous observations, indicating E. coli harboring blaCTX-M-type gene as rapid and effective biofilm developers [13].
In this study, we also investigated the associations between biofilm production and several virulence factors encoding adhesins, invasins, and quorum sensing that might be involved in the initial bacterial adhesion process to surfaces and in the establishment of the mature biofilm. The presence of operons csgBAC and csgDEFG was correlated with increased biofilm production. Indeed, csgBAC genes encode curli fibers, which have been linked to biofilm formation in E. coli and other enterobacteria [14], while proteins encoded by csgDEFG genes regulate the transcription from the csgBAC promoter (CsgD) and are involved in curli assembly and stability (CsgE, CsgF, and CsgG) [15]. Previous studies suggest that curli fibers may play a key role during infection, particularly in the attachment and invasion of host cells [16], interaction with host proteins [17], and activation of the immune system [18], highlighting the risk for human health posed by biofilm-producing ESBL/pAmpC-EC. Operon matABCDEF is known to be involved in the early stages of biofilm formation, and defective E. coli has been shown to have a reduced ability to form biofilms [19]. Accordingly, in our study, strains carrying the entire operon showed higher biofilm production compared to those lacking one or more of these genes. Increased biofilm formation was also observed in the presence of the sfaX gene. Although the function of the encoded protein has not yet been elucidated, it seems to have a regulatory role affecting the expression of surface structures, such as type 1 fimbriae and flagella [20], which are associated with an increased biofilm formation capability in E. coli [21]. Our data seem to suggest that the SfaX protein might enhance biofilm production, possibly by promoting fimbrial expression [22], although transcription or expression studies are needed to support such a hypothesis. Tsh gene, which encodes a temperature-sensitive hemagglutinin member of the autotransporter group of proteins, was the only gene associated with a reduction in biofilm formation capability. Tsh has been identified in E. coli isolated from different sources [23] and has been associated with extraintestinal infection and virulence of Avian Pathogenic E. coli (APEC) [24]. Despite its role in APEC virulence and the fact that autotransporter proteins are recognized to be implicated in different virulence functions, including adherence to and invasion of host cells, our findings seem in agreement with previous observations, suggesting that the Tsh protein does not enhance biofilm formation [25,26]. All strains lacked the mrkABCDF operon, encoding for the type 3 fimbriae, which enhances biofilm formation [27], but possessed the pgaC gene, encoding for the synthesis of the PGA polymer, which is involved in the early stages of biofilm formation by promoting the adhesion to abiotic surfaces [13]. Remarkably, all strains showed the hha gene encoding a protein involved in the suppression of fimbrial genes (fim) transcription and playing a dual role in the biofilm cycle. Indeed, its expression in planktonic E. coli can hinder initial biofilm formation, whereas within mature biofilms it can promote cell detachment from the biofilm, cell dispersal, and colonization of new ecological niches [28]. The study is limited to assessing the presence of biofilm formation-associated genes, but no transcription and/or expression analysis was carried out. Future studies should aim at investigating the expression of the identified genes, allowing us to improve the knowledge regarding the genetic factors influencing the biofilm formation ability of ESBL/pAmpC-EC.

4. Materials and Methods

4.1. Bacterial Strains

One hundred and two ESBL/pAmpC-producing E. coli isolated from three production chains (i.e., A, B and C) of an integrated broiler production company located in Northern Italy were included in this study (Table S2) [11]. Briefly, in each chain, cloacal swabs were first collected from broiler breeders at two time-points, i.e., at 1 day of age (breeder chicks) and 21 weeks of age (breeders), and then from the offspring in four fattening farms at 1 (broiler chicks) and 30 days of age (broilers). Carcasses were sampled at the slaughterhouse by rinsing the whole carcass with buffer peptone water. E. coli were screened for ESBL/pAmpC using a selective medium (Eosin Methylene Blue agar (Microbiol, Italy) supplemented with 1 mg/L cefotaxime (CTX-EMB) and incubated at 37 ± 0.5 °C for 20 ± 2 h; ESBL/pAmpC production was assessed by double-disk synergy according to CLSI guidelines [29]. Phylogroups characterization and antimicrobial resistance genes (ARGs) detection were carried out by multiplex PCR [11]. Strains were selected based on the production chain, production stage, ESBL/pAmpC gene, and phylogroup combinations, and underwent whole genome sequencing [30,31]. Raw reads were assembled using the Enterobase database (https://enterobase.readthedocs.io, accessed on 28 December 2020) and the obtained contigs were used for the comparative genomics analysis (Table S2).

4.2. Microtitre Plate Assay for the Detection and Quantification of Biofilm Formation

The biofilm formation was assessed using a microtiter plate assay based on the protocol published by Stefanovic et al. (2000). Each strain was tested in triplicate on two different experiments (six replicates per sample). In detail, E. coli strains were incubated in brain heart infusion (BHI) broth (Microbiol, Uta, Italy) at 37 ± 1 °C for 24 h. Subsequently, aliquots were diluted until reaching the turbidity of 1 on the McFarland scale, and 200 µL of each bacterial suspension were inoculated in triplicate into a 96-well sterile polystyrene microplate (Sarstedt, Numbrecht, Germany). In each plate, three wells were inoculated with sterile BHI as negative control. Plates were incubated on a shaker at 37 ± 1 °C for 24 h. After incubation, the bacterial suspensions were removed and wells were washed three times with 0.9% sodium chloride solution (250 µL). Bacteria were then fixed using methanol (200 µL) and incubated at room temperature for 15 min (min). Subsequently, bacteria were stained with 200 µL crystal violet (Fisher Scientific, Waltham, USA) for 5 min, then the dye was washed with running water and dried at room temperature. Eventually, the dye bound to the cells adhering to the wells was re-solubilized with 160 µL of 33% glacial acetic acid and plates were read three times at 5 min intervals using a spectrophotometer (MultiskanTM GO, Fisher Scientific) at 570 nm. The O.D. value of each strain (O.D.S) was calculated as the arithmetic mean of the absorbance of the replicates over the two experiments. Standard deviation and coefficient of variation (CV) were also calculated to assess the robustness of the data (CV < 0.5). O.D.S values were compared with the mean O.D. of the negative control (O.D.NC), and strains were subsequently classified into four different categories: (1) non biofilm producers (O.D.S ≤ O.D.NC); (2) weak biofilm producers (O.D.NC < O.D.S ≤ 2 × O.D.NC); (3) moderate biofilm producers (2 × O.D.NC < O.D.S ≤ 4 × O.D.NC); and (4) strong biofilm producers (O.D.S > 4 × O.D.NC) [32].

4.3. Statistical Analysis and Comparative Genomics

Association between the explanatory variables (i.e., stage, chain, phylogroup, and ESBL/pAmpC gene) was assessed using chi-square and Fisher’s exact test.
Assembled contigs were screened against a dataset containing the sequences of genes associated with biofilm formation (Table S1) using MyDbFinder 2.0 (https://cge.food.dtu.dk/services/MyDbFinder/, accessed on 24 August 2022).
The correlation between the ability to form biofilms and the frequency of virulence-associated genes was assessed using hierarchical clustering based on the presence/absence of each gene using the pHeatmap package version 1.0.12 in R version 4.1.2 (https://www.r-project.org/, accessed on 3 November 2022). The corrected mean O.D. was calculated for each strain as the mean of six independent replicates, minus the O.D. of the negative control. Differences in the corrected mean O.D. between groups (i.e., chain, stage, phylogroup, and ESBL/pAmpC genes) were assessed using the non-parametric Kruskal–Wallis test, while the association between corrected mean O.D. and the frequency of biofilm-associated genes was investigated with the Mann–Whitney test. The statistical analyses were performed using GraphPad Prims v9.4.1 software (http://www.graphpad.com, accessed on 6 October 2022).

5. Conclusions

In the present study, the biofilm formation ability of E. coli-carrying ESBL/pAmpC genes isolated from the poultry sector was investigated. Remarkably, biofilm-producing ESBL/pAmpC-EC were isolated through the broiler production pyramid, and this represents a great risk for public health, since they might persist at various points of the food chain and reach humans via the manipulation and consumption of contaminated food. ESBL/pAmpC-EC in biofilms can also act as spreaders of genes conferring resistance to third generation cephalosporins, which are critically important antimicrobials. To reduce the risk of human exposure to biofilm-producing ESBL/pAmpC-EC, intervention and mitigation strategies should be employed in poultry farms (e.g., increased biosecurity and disinfection measures) and slaughterhouses (e.g., disinfection of the processing line) to avoid the colonization of birds from environmental sources and the cross-contamination of poultry meat, respectively. Strains harboring adhesion and invasion genes were associated with increased biofilm formation ability, but future studies should be carried out to establish their role in biofilm formation.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12010155/s1, Table S1: List of biofilm-associated genes identified in the investigate ESBL/pAmpC-producing E. coli; Table S2: Dataset of biofilm-associated genes used in this study.

Author Contributions

Conceptualization, A.L. and A.P.; methodology, R.T. and A.L.; formal analysis, A.L.; investigation, R.T. and A.L.; resources, A.P. and I.A.; data curation, A.L. and R.T.; writing—original draft preparation, A.L.; writing—review and editing, A.L., A.P., I.A. and R.T.; visualization, A.L.; supervision, A.P.; project administration, A.L. and A.P.; funding acquisition, A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would like to acknowledge Nico Tosetto and Maria Teresa Valerio for their support in analyzing the biofilm producing ability of ESBL/pAmpC E. coli strains and Luca Fasolato (Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro (PD), 35020, Italy) for his support during carcasses sampling and E. coli isolation and identification from broiler carcasses.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Boucher, H.W.; Talbot, G.H.; Bradley, J.S.; Edwards, J.E.; Gilbert, D.; Rice, L.B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Brolund, A.; Sandegren, L. Characterization of ESBL Disseminating Plasmids. Infect. Dis. 2016, 48, 18–25. [Google Scholar] [CrossRef] [PubMed]
  3. Maheshwari, M.; Ahmad, I.; Althubiani, A.S. Multidrug Resistance and Transferability of BlaCTX-M among Extended-Spectrum β-Lactamase-Producing Enteric Bacteria in Biofilm. J. Glob. Antimicrob. Resist. 2016, 6, 142–149. [Google Scholar] [CrossRef] [PubMed]
  4. Van Meervenne, E.; De Weirdt, R.; Van Coillie, E.; Devlieghere, F.; Herman, L.; Boon, N. Biofilm Models for the Food Industry: Hot Spots for Plasmid Transfer? Pathog. Dis. 2014, 70, 332–338. [Google Scholar] [CrossRef]
  5. Donlan, R.M.; Costerton, J.W. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clin. Microbiol. Rev. 2002, 15, 167–193. [Google Scholar] [CrossRef] [Green Version]
  6. Sun, Y.; Hu, X.; Guo, D.; Shi, C.; Zhang, C.; Peng, X.; Yang, H.; Xia, X. Disinfectant Resistance Profiles and Biofilm Formation Capacity of Escherichia Coli Isolated from Retail Chicken. Microb. Drug Resist. 2019, 25, 703–711. [Google Scholar] [CrossRef] [PubMed]
  7. Lazarus, B.; Paterson, D.L.; Mollinger, J.L.; Rogers, B.A. Do Human Extraintestinal Escherichia Coli Infections Resistant to Expanded-Spectrum Cephalosporins Originate from Food-Producing Animals? A Systematic Review. Clin. Infect. Dis. 2015, 60, 439–452. [Google Scholar] [CrossRef] [Green Version]
  8. Silagyi, K.; Kim, S.H.; Martin Lo, Y.; Wei, C.-i. Production of Biofilm and Quorum Sensing by Escherichia Coli O157:H7 and Its Transfer from Contact Surfaces to Meat, Poultry, Ready-to-Eat Deli, and Produce Products. Food Microbiol. 2009, 26, 514–519. [Google Scholar] [CrossRef]
  9. Subramanian, P.; Umadevi, S.; Kumar, S.; Stephen, S. Determination of Correlation between Biofilm and Extended Spectrum β Lactamases Producers of Enterobacteriaceae. Sch. Res. J. 2012, 2, 2. [Google Scholar] [CrossRef]
  10. Neupane, S.; Pant, N.D.; Khatiwada, S.; Chaudhary, R.; Banjara, M.R. Correlation between Biofilm Formation and Resistance toward Different Commonly Used Antibiotics along with Extended Spectrum Beta Lactamase Production in Uropathogenic Escherichia Coli Isolated from the Patients Suspected of Urinary Tract Infections Visit. Antimicrob. Resist. Infect. Control 2016, 5, 5. [Google Scholar] [CrossRef]
  11. Apostolakos, I.; Mughini-Gras, L.; Fasolato, L.; Piccirillo, A. Assessing the Occurrence and Transfer Dynamics of ESBL/PAmpC-Producing Escherichia Coli across the Broiler Production Pyramid. PLoS One 2019, 14, e0217174. [Google Scholar] [CrossRef] [Green Version]
  12. Dame-Korevaar, A.; Fischer, E.A.J.; van der Goot, J.; Stegeman, A.; Mevius, D. Transmission Routes of ESBL/PAmpC Producing Bacteria in the Broiler Production Pyramid, a Literature Review. Prev. Vet. Med. 2019, 162, 136–150. [Google Scholar] [CrossRef]
  13. Surgers, L.; Boyd, A.; Girard, P.M.; Arlet, G.; Decré, D. Biofilm Formation by ESBL-Producing Strains of Escherichia Coli and Klebsiella Pneumoniae. Int. J. Med. Microbiol. 2019, 309, 13–18. [Google Scholar] [CrossRef]
  14. Barnhart, M.M.; Chapman, M.R. Curli Biogenesis and Function. Annu. Rev. Microbiol. 2006, 60, 131–147. [Google Scholar] [CrossRef] [Green Version]
  15. Brombacher, E.; Baratto, A.; Dorel, C.; Landini, P. Gene Expression Regulation by the Curli Activator CsgD Protein: Modulation of Cellulose Biosynthesis and Control of Negative Determinants for Microbial Adhesion. J. Bacteriol 2006, 188, 2027–2037. [Google Scholar] [CrossRef] [Green Version]
  16. Bian, Z.; Brauner, A.; Li, Y.; Normark, S. Expression of and Cytokine Activation by Escherichia Coli Curli Fibers in Human Sepsis. J. Infect. Dis. 2000, 181, 602–612. [Google Scholar] [CrossRef] [Green Version]
  17. Olsén, A.; Herwald, H.; Wikström, M.; Persson, K.; Mattsson, E.; Björck, L. Identification of Two Protein-Binding and Functional Regions of Curli, a Surface Organelle and Virulence Determinant of Escherichia Coli. J. Biol. Chem. 2002, 277, 34568–34572. [Google Scholar] [CrossRef] [Green Version]
  18. Olsén, A.; Wick, M.J.; Mörgelin, M.; Björck, L. Curli, Fibrous Surface Proteins of Escherichia Coli, Interact with Major Histocompatibility Complex Class I Molecules. Infect. Immun. 1998, 66, 944–949. [Google Scholar] [CrossRef] [Green Version]
  19. Lehti, T.A.; Bauchart, P.; Heikkinen, J.; Hacker, J.; Korhonen, T.K.; Dobrindt, U.; Westerlund-Wikström, B. Mat Fimbriae Promote Biofilm Formation by Meningitis-Associated Escherichia Coli. Microbiology 2010, 156, 2408–2417. [Google Scholar] [CrossRef] [Green Version]
  20. Sjöström, A.E.; Sondén, B.; Müller, C.; Rydström, A.; Dobrindt, U.; Wai, S.N.; Uhlin, B.E. Analysis of the SfaXII Locus in the Escherichia Coli Meningitis Isolate IHE3034 Reveals Two Novel Regulatory Genes within the Promoter-Distal Region of the Main S Fimbrial Operon. Microb. Pathog. 2009, 46, 150–158. [Google Scholar] [CrossRef]
  21. Blumer, C.; Kleefeld, A.; Lehnen, D.; Heintz, M.; Dobrindt, U.; Nagy, G.; Michaelis, K.; Emödy, L.; Polen, T.; Rachel, R.; et al. Regulation of Type 1 Fimbriae Synthesis and Biofilm Formation by the Transcriptional Regulator LrhA of Escherichia Coli. Microbiology 2005, 151, 3287–3298. [Google Scholar] [CrossRef] [Green Version]
  22. Paracuellos, P.; Öhman, A.; Sauer-Eriksson, A.E.; Uhlin, B.E. Expression and Purification of SfaXII, a Protein Involved in Regulating Adhesion and Motility Genes in Extraintestinal Pathogenic Escherichia Coli. Protein Expr. Purif. 2012, 86, 127–134. [Google Scholar] [CrossRef] [Green Version]
  23. Hammad, A.M.; Escalona, N.G.; El Tahan, A.; Abbas, N.H.; Koenig, S.S.K.; Guardia, A.A.; Eppinger, M.; Hoffmann, M. Pathogenome Comparison and Global Phylogeny of Escherichia Coli ST1485 Strains. Sci. Rep. 2022, 12, 18495. [Google Scholar] [CrossRef]
  24. Dozois, C.M.; Dho-Moulin, M.; Brée, A.; Fairbrother, J.M.; Desautels, C.; Curtiss, R. Relationship between the Tsh Autotransporter and Pathogenicity of Avian Escherichia Coli and Localization and Analysis of the Tsh Genetic Region. Infect. Immun. 2000, 68, 4145–4154. [Google Scholar] [CrossRef] [Green Version]
  25. Crecencio, R.B.; Brisola, M.C.; Bitner, D.; Frigo, A.; Rampazzo, L.; Borges, K.A.; Furian, T.Q.; Salle, C.T.P.; Moraes, H.L.S.; Faria, G.A.; et al. Antimicrobial Susceptibility, Biofilm Formation and Genetic Profiles of Escherichia Coli Isolated from Retail Chicken Meat. Infect. Genet. Evol. 2020, 84, 104355. [Google Scholar] [CrossRef]
  26. Naves, P.; Del Prado, G.; Huelves, L.; Gracia, M.; Ruiz, V.; Blanco, J.; Rodríguez-Cerrato, V.; Ponte, M.C.; Soriano, F. Measurement of Biofilm Formation by Clinical Isolates of Escherichia Coli Is Method-Dependent. J. Appl. Microbiol. 2008, 105, 585–590. [Google Scholar] [CrossRef]
  27. Burmølle, M.; Bahl, M.I.; Jensen, L.B.; Sørensen, S.J.; Hansen, L.H. Type 3 Fimbriae, Encoded by the Conjugative Plasmid POLA52, Enhance Biofilm Formation and Transfer Frequencies in Enterobacteriaceae Strains. Microbiology 2008, 154, 187–195. [Google Scholar] [CrossRef] [Green Version]
  28. García-Contreras, R.; Zhang, X.S.; Kim, Y.; Wood, T.K. Protein Translation and Cell Death: The Role of Rare TRNAs in Biofilm Formation and in Activating Dormant Phage Killer Genes. PLoS One 2008, 3, e2394. [Google Scholar] [CrossRef]
  29. CLSI Performance Standards for Antimicrobial Susceptibility Testing, 27th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2017; Volume 18, pp. 461–466.
  30. Apostolakos, I.; Feudi, C.; Eichhorn, I.; Palmieri, N.; Fasolato, L.; Schwarz, S.; Piccirillo, A. High-Resolution Characterisation of ESBL/PAmpC-Producing Escherichia Coli Isolated from the Broiler Production Pyramid. Sci. Rep. 2020, 10, 11123. [Google Scholar] [CrossRef]
  31. Apostolakos, I.; Laconi, A.; Mughini-Gras, L.; Yapicier, Ö.Ş.; Piccirillo, A. Occurrence of Colibacillosis in Broilers and Its Relationship with Avian Pathogenic Escherichia Coli (APEC) Population Structure and Molecular Characteristics. Front. Vet. Sci. 2021, 8, 737720. [Google Scholar] [CrossRef]
  32. Stepanović, S.; Vuković, D.; Dakić, I.; Savić, B.; Švabić-Vlahović, M. A Modified Microtiter-Plate Test for Quantification of Staphylococcal Biofilm Formation. J. Microbiol. Methods 2000, 40, 175–179. [Google Scholar] [CrossRef] [PubMed]
Antibiotics 12 00155 g001 550
Figure 1. Corrected mean optical density (O.D.) values of the different biofilm classes. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as * and p < 0.0001 as ****.
Figure 1. Corrected mean optical density (O.D.) values of the different biofilm classes. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as * and p < 0.0001 as ****.
Antibiotics 12 00155 g001
Antibiotics 12 00155 g002 550
Figure 2. (a) Distribution of biofilm formation classes, presented as cumulative percentage of strains, and (b) corrected mean O.D. among production chains. (c) Distribution of biofilm formation classes, presented as cumulative percentage of strains, and (d) corrected mean O.D. among production stages. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.01 is shown as **.
Figure 2. (a) Distribution of biofilm formation classes, presented as cumulative percentage of strains, and (b) corrected mean O.D. among production chains. (c) Distribution of biofilm formation classes, presented as cumulative percentage of strains, and (d) corrected mean O.D. among production stages. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.01 is shown as **.
Antibiotics 12 00155 g002
Antibiotics 12 00155 g003 550
Figure 3. (a) Corrected mean O.D. among phylogroups. (b) Corrected mean O.D. among strains harboring different ESBL/pAmpC genes. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as *, p < 0.005 as ***, and p < 0.0001 as ****.
Figure 3. (a) Corrected mean O.D. among phylogroups. (b) Corrected mean O.D. among strains harboring different ESBL/pAmpC genes. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as *, p < 0.005 as ***, and p < 0.0001 as ****.
Antibiotics 12 00155 g003
Antibiotics 12 00155 g004 550
Figure 4. Hierarchical clustering analyses based on average linkage distance and Euclidean distance measurement methods showing the clustering pattern of ESBL/pAmpC-EC strains (n = 102) and variable virulence genes (n = 21). Nodes shape and color indicate the broiler production stage and production chain, respectively. The inner stripe indicates the biofilm classes. The middle stripe indicates the phylogroups. The outer ring specifies the ESBL/pAmpC genes identified.
Figure 4. Hierarchical clustering analyses based on average linkage distance and Euclidean distance measurement methods showing the clustering pattern of ESBL/pAmpC-EC strains (n = 102) and variable virulence genes (n = 21). Nodes shape and color indicate the broiler production stage and production chain, respectively. The inner stripe indicates the biofilm classes. The middle stripe indicates the phylogroups. The outer ring specifies the ESBL/pAmpC genes identified.
Antibiotics 12 00155 g004
Antibiotics 12 00155 g005 550
Figure 5. Corrected mean O.D. of strains harboring (blue) and lacking (red) operons csgBAC, csgDEFG, and matABCDEF and genes sfaX and tsh. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as *, p < 0.01 as **, and p < 0.0001 as ****.
Figure 5. Corrected mean O.D. of strains harboring (blue) and lacking (red) operons csgBAC, csgDEFG, and matABCDEF and genes sfaX and tsh. Lines within violin plots represent median, 25th, and 75th percentile. p < 0.05 is shown as *, p < 0.01 as **, and p < 0.0001 as ****.
Antibiotics 12 00155 g005
Table
Table 1. Ability to form biofilms by ESBL/pAmpC-EC according to production chain and production stage.
Table 1. Ability to form biofilms by ESBL/pAmpC-EC according to production chain and production stage.
Non-Biofilm ProducersWeak ProducersModerate ProducersStrong Producers
Percentage (%)95% (CI)Percentage (%)95% (CI)Percentage (%)95% (CI)Percentage (%)95% (CI)
Chain
Chain A (n = 37)0.00%0.00%54.05%37.21–70.90%40.54%23.94–57.14%5.41%00.00–13.05%
Chain B (n = 33)3.03%0.00–9.20%57.58%39.78–75.37%30.30%13.75–46.85%9.09%0.00–19.44%
Chain C (n = 32)0.00%0.00%75.00%59.14–90.86%18.75%4.45–33.05%6.25%0.00–15.12%
Production stage
Breeder chicks (n = 5)0.00%0.00%80.00%24.47–100%20.00%0.00–75.53%0.00%0.00%
Breeders (n = 10)0.00%0.00%50.00%12.30–87.70%40.00%3.06–76.94%10.00%0.00–32.62%
Broiler chicks (n = 26)3.85%0.00–11.77%69.23%50.22–88.24%23.08%5.72–40.43%3.85%0.00–11.77%
Broilers (n = 28)0.00%0.00%50.00%30.26–69.74%35.71%16.79–54.64%14.29%0.47–28.10%
Carcasses (n = 33)0.00%0.00%66.67%49.69–83.64%30.30%13.75–46.85%3.03%0.00–9.20%
Table
Table 2. Ability to form biofilms by ESBL/pAmpC-EC, according to phylogroup and ESBL/pAmpC gene.
Table 2. Ability to form biofilms by ESBL/pAmpC-EC, according to phylogroup and ESBL/pAmpC gene.
Non-Biofilm Producer Weak ProducersModerate ProducersStrong Producers
Percentage (%)95% (CI)Percentage (%)95% (CI)Percentage (%)95% (CI)Percentage (%)95% (CI)
Phylogroup
Phylogroup A (n = 22)4.55%0.00–14.00%77.27%58.25–96.29%18.18%0.68–35.68%0.00%0.00%
Phylogroup B1 (n = 18)0.00%0.00%38.89%13.94–63.83%50.00%24.41–75.59%11.11%0.00–27.19%
Phylogroup B2 (n = 12)0.00%0.00%91.67%73.33–100.0%8.33%0.00–26.67%0.00%0.00%
Phylogroup C (n = 2)0.00%0.00%100.00%100.00%0.00%0.00%0.00%0.00%
Phylogroup D (n = 9)0.00%0.00%55.56%15.04–96.07%33.33%0.00–71.77%11.11%0.00–36.73%
Phylogroup E (n = 9)0.00%0.00%44.44%3.93–84.86%33.33%0.00–71.77%22.22%0.00–56.12%
Phylogroup F (n = 30)0.00%0.00%56.67%37.85–75.49%36.67%18.36–54.97%6.67%0.00–16.14%
ESBL/pAmpC
blaCMY-2 (n = 30)3.33%0.00–10.15%76.67%60.60–92.73%20.00%4.81–35.19%0.00%0.00%
blaCTX-M-type (n = 49)0.00%0.00%51.02%36.51–65.53%40.82%26.55–55.08%8.16%0.22–16.11%
blaSHV (n = 20)0.00%0.00%70.00%48.00–92.00%20.00%0.79–39.21%10.00%0.00–24.41%
blaTEM-52B (n = 2)0.00%0.00%0.00%0.00%50.00%0.00–100.00%50.00%0.00–100.00%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Laconi, A.; Tolosi, R.; Apostolakos, I.; Piccirillo, A. Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid. Antibiotics 2023, 12, 155. https://doi.org/10.3390/antibiotics12010155

AMA Style

Laconi A, Tolosi R, Apostolakos I, Piccirillo A. Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid. Antibiotics. 2023; 12(1):155. https://doi.org/10.3390/antibiotics12010155

Chicago/Turabian Style

Laconi, Andrea, Roberta Tolosi, Ilias Apostolakos, and Alessandra Piccirillo. 2023. "Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid" Antibiotics 12, no. 1: 155. https://doi.org/10.3390/antibiotics12010155

APA Style

Laconi, A., Tolosi, R., Apostolakos, I., & Piccirillo, A. (2023). Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid. Antibiotics, 12(1), 155. https://doi.org/10.3390/antibiotics12010155

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop